JP2015512936A5 - - Google Patents

Download PDF

Info

Publication number
JP2015512936A5
JP2015512936A5 JP2015505730A JP2015505730A JP2015512936A5 JP 2015512936 A5 JP2015512936 A5 JP 2015512936A5 JP 2015505730 A JP2015505730 A JP 2015505730A JP 2015505730 A JP2015505730 A JP 2015505730A JP 2015512936 A5 JP2015512936 A5 JP 2015512936A5
Authority
JP
Japan
Prior art keywords
fucosyl
sialyl lactose
prebiotic composition
oligosaccharide
sialyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015505730A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015512936A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/030764 external-priority patent/WO2013154725A1/en
Publication of JP2015512936A publication Critical patent/JP2015512936A/ja
Publication of JP2015512936A5 publication Critical patent/JP2015512936A5/ja
Pending legal-status Critical Current

Links

JP2015505730A 2012-04-13 2013-03-13 プレバイオティクス組成物およびその使用方法 Pending JP2015512936A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261623868P 2012-04-13 2012-04-13
US61/623,868 2012-04-13
PCT/US2013/030764 WO2013154725A1 (en) 2012-04-13 2013-03-13 Prebiotic compositions and methods of use

Publications (2)

Publication Number Publication Date
JP2015512936A JP2015512936A (ja) 2015-04-30
JP2015512936A5 true JP2015512936A5 (enExample) 2016-05-12

Family

ID=49328018

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015505730A Pending JP2015512936A (ja) 2012-04-13 2013-03-13 プレバイオティクス組成物およびその使用方法

Country Status (6)

Country Link
US (1) US20150265661A1 (enExample)
EP (1) EP2836218A4 (enExample)
JP (1) JP2015512936A (enExample)
CN (1) CN104507483A (enExample)
MX (1) MX2014012362A (enExample)
WO (1) WO2013154725A1 (enExample)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012532195A (ja) 2009-07-06 2012-12-13 チルドレンズ ホスピタル メディカル センター 乳オリゴ糖による炎症の阻害
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
CN114949001A (zh) 2012-08-29 2022-08-30 加州理工学院 孤独症谱系障碍的诊断和治疗
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
EP2885977A1 (en) * 2013-12-19 2015-06-24 Agriculture and Food Development Authority (TEAGASC) An oligosaccharide-enriched composition having immune-modulatory and anti-adhesion properties
US20150305385A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
CN107108677B (zh) 2014-10-24 2020-08-07 格礼卡姆股份公司 Hmo的混合物
US20160346303A1 (en) * 2014-10-29 2016-12-01 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US20170258820A1 (en) * 2014-10-29 2017-09-14 Glycom A/S Synthetic composition and method for promoting mucosal healing
US11040049B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
KR20170086492A (ko) 2014-10-30 2017-07-26 캘리포니아 인스티튜트 오브 테크놀로지 신경발달 장애에서의 행동을 개선시키기 위한 박테리아를 포함하는 조성물 및 방법
US10124025B2 (en) 2014-10-30 2018-11-13 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
CN107106584A (zh) 2014-12-08 2017-08-29 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
AU2018205072B2 (en) * 2014-12-23 2020-05-21 Cj Bioscience, Inc. Immune modulation
DK3193901T3 (en) 2014-12-23 2018-05-28 4D Pharma Res Ltd PIRIN POLYPEPTIDE AND IMMUNMODULATION
PE20171138A1 (es) * 2014-12-23 2017-08-09 4D Pharma Res Ltd Modulacion inmunitaria
US10857167B2 (en) 2015-04-28 2020-12-08 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
EP3662917A1 (en) 2015-06-15 2020-06-10 4D Pharma Research Limited Compositions comprising bacterial strains
PE20180243A1 (es) 2015-06-15 2018-01-31 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
LT3360559T (lt) 2015-06-15 2019-12-27 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
WO2017071715A1 (en) 2015-10-28 2017-05-04 Glycom A/S Synthetic composition and method for modulating brain function and behaviour
US10780103B2 (en) 2015-10-28 2020-09-22 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
EP3377071B1 (en) * 2015-11-17 2024-01-10 Glycom A/S Human milk oligosaccharides for treating antibiotic associated complications
MA41013A (fr) 2015-11-20 2017-08-30 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN108541221B (zh) 2015-12-15 2023-02-28 格礼卡姆股份公司 Hmo的混合物
MX373290B (es) 2016-03-04 2020-06-18 4D Pharma Plc Composiciones que comprenden cepas bacterianas.
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
AU2017234120B2 (en) 2016-03-14 2024-06-20 Holobiome, Inc. Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
ES2938355T3 (es) * 2016-05-05 2023-04-10 Glycom As Composición que comprende HMOS para el tratamiento de la diarrea no infecciosa
US11224605B2 (en) 2016-05-19 2022-01-18 Glycom A/S Synthetic composition
CA3029631A1 (en) * 2016-07-01 2018-01-04 Evolve Biosystems, Inc. Method for facilitating maturation of the mammalian immune system
TWI802545B (zh) 2016-07-13 2023-05-21 英商4D製藥有限公司 包含細菌菌株之組合物
CA3030809A1 (en) 2016-07-28 2018-02-01 Fonterra Co-Operative Group Limited Sialyloligosaccharide product and process
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
US11566238B2 (en) 2016-12-15 2023-01-31 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for modulating growth of a genetically modified gut bacterial cell
KR102019364B1 (ko) * 2017-02-27 2019-09-06 한국생명공학연구원 시아릴락토오스를 유효성분으로 포함하는 항균용 조성물
US20200129534A1 (en) * 2017-04-07 2020-04-30 Children's Hospital Medical Center Treatment of inflammatory bowel diseases with 2'-fucosyllactose compounds
MA48940A (fr) 2017-05-22 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41708A (fr) 2017-05-24 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PL3638271T3 (pl) 2017-06-14 2021-03-22 4D Pharma Research Limited Kompozycje zawierające szczepy bakteryjne
JP2020523326A (ja) 2017-06-14 2020-08-06 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
TWI767013B (zh) 2017-06-14 2022-06-11 英商4D製藥研究有限公司 包含細菌品系之組成物
KR20260033622A (ko) * 2017-10-04 2026-03-10 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 면역조절성 올리고사카라이드
EP3716983A4 (en) * 2017-11-30 2022-03-02 Glycom A/S HUMAN MILK OLIGOSACCHARIDES AND SYNTHETIC COMPOSITIONS THEREOF FOR MICROBIOTA MODULATION
EP3743078A4 (en) 2017-12-22 2022-01-19 Glycom A/S COMPOSITION WITH HMOs TO PREVENT OR REDUCE NOCICEPTION
US20210069088A1 (en) * 2018-03-08 2021-03-11 Plexus Worldwide, LLC. Compositions and methods for skin renewal
CN108935698A (zh) * 2018-09-11 2018-12-07 内蒙古伊利实业集团股份有限公司 一种预防小儿腹泻疾病的营养组合物及应用
US20220022515A1 (en) 2019-02-25 2022-01-27 Nutribam Bv Composition, Food Supplement and Method for Supporting and/or Improving Intestinal Health
BE1027078A9 (nl) * 2019-02-25 2020-09-28 Nutribam Bvba Samenstelling, voedingssupplement en werkwijze voor het ondersteunen en/of verbeteren van de darmgezondheid
CN110257299B (zh) * 2019-07-11 2022-06-10 锦州医科大学 一种阴沟肠杆菌在促进反刍动物生长的应用
CN118020940A (zh) * 2019-11-29 2024-05-14 内蒙古伊利实业集团股份有限公司 副干酪乳杆菌k56提升肠道细菌感染抗性和肠道免疫力的应用
JP7474596B2 (ja) * 2020-01-20 2024-04-25 森永乳業株式会社 新規ビフィドバクテリウム属細菌、および当該細菌を含む組成物、並びに当該細菌の増殖促進用の組成物
CN111363671B (zh) * 2020-02-26 2023-07-21 天津医科大学 一种肠道厌氧微生物培养瓶及其制备方法
WO2021197492A1 (zh) * 2020-04-03 2021-10-07 内蒙古伊利实业集团股份有限公司 可提升生物体对金黄色葡萄球菌感染的抵御能力的母乳低聚糖
CN112075637B (zh) * 2020-04-27 2023-05-23 合生元(广州)健康产品有限公司 一种减少肠道气体产生的组合物
CN112841543A (zh) * 2021-01-28 2021-05-28 重庆周师兄餐饮文化有限公司 一种麻辣脆的加工方法
EP4284193B1 (en) 2021-01-29 2025-05-07 Société des Produits Nestlé S.A. Mixture of hmos and bifidobacteria
CN112890200B (zh) * 2021-03-08 2021-11-12 合生元(广州)健康产品有限公司 用于促进低体重婴幼儿生长追赶的一种营养组合物
WO2022223430A1 (en) * 2021-04-19 2022-10-27 Dsm Ip Assets B.V. A composition of enzymes and human milk oligosaccharides
WO2023281099A1 (en) * 2021-07-09 2023-01-12 Société des Produits Nestlé S.A. Uses of bifidobacterium longum transitional microorganism
CN113796545B (zh) * 2021-09-13 2022-09-13 合生元(广州)健康产品有限公司 调节肠道免疫功能的母乳低聚糖组合物及其应用
KR102411242B1 (ko) * 2021-10-18 2022-06-22 큐티스바이오 주식회사 클렙시엘라 아에로제네스의 피부 상태 개선 용도
DK202200588A1 (en) 2022-06-20 2024-02-23 Dsm Ip Assets Bv Mixture of fucosylated HMOs
CN115920013A (zh) * 2022-11-15 2023-04-07 合生元(广州)健康产品有限公司 乳源成分在降低单增李斯特菌引起的感染风险中的应用
CN116042486B (zh) * 2023-02-22 2024-11-08 高邮市人民医院 一种用于治疗动脉粥样硬化的复合菌制剂
WO2026053964A1 (ja) * 2024-09-04 2026-03-12 株式会社ヤクルト本社 新規ビフィドバクテリウム属細菌とその利用
CN121987674B (zh) * 2026-04-10 2026-06-23 江苏汉典生物科技股份有限公司 一种能促进肠道菌群增殖的合生元组合物及制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630452B2 (en) * 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
US20060127546A1 (en) * 2004-08-27 2006-06-15 Purac Biochem B.V. Use of glycine and/or glycine derivatives as antibacterial agent against gram negative bacterial pathogens in foods and/or drinks
JP2012532195A (ja) * 2009-07-06 2012-12-13 チルドレンズ ホスピタル メディカル センター 乳オリゴ糖による炎症の阻害
FI20096400A0 (fi) * 2009-12-28 2009-12-28 Suomen Punainen Risti Veripalv Veriryhmästatuksen käyttö I
WO2011136647A1 (en) * 2010-04-27 2011-11-03 N.V. Nutricia Use of 6'-sialyl lactose in infant and toddler nutrition
EP2465508A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
NZ611807A (en) * 2010-12-31 2015-02-27 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
AU2012215042B2 (en) * 2011-02-10 2016-01-14 Société des Produits Nestlé S.A. Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk

Similar Documents

Publication Publication Date Title
CN302072736S (zh) 水龙头(hda1715l)
CN302064961S (zh) 水龙头(hda1815l)
CN302082441S (zh) 水龙头(hda1818xh)
CN302061246S (zh) 门夹(2745)
CN302533123S (zh) 全封闭冰箱门锁(二)
CN302155520S (zh) 水龙头(面盆-0008)
CN302494801S (zh) 拉手(7)
CN302494800S (zh) 拉手(6)
CN302357289S (zh) 炕几(816095)
CN302443791S (zh) 柜子(高柜)
CN302570606S (zh) 洋间扇(s35115r、s35116rt)
CN302487805S (zh) 拉手(5)
CN302155521S (zh) 水龙头(面盆-0006)
CN302134782S (zh) 水龙头(面盆-0007)
CN301597406S (zh) 汽车外饰件大包围
CN302533098S (zh) 拉手(1)
CN302533124S (zh) 全封闭冰箱门锁(一)
CN302527087S (zh) 冰箱(165)
CN302527081S (zh) 冰箱(167)
CN302527080S (zh) 冰箱(169)
CN302552769S (zh) 花洒(th3190)
CN302439651S (zh) 锁内面板(04款)
CN302494849S (zh) 门锁前锁体(圆形/椭圆形)
CN302103675S (zh) 柜子(y-06)
CN302176827S (zh) 淋浴龙头(0025)